Hims & Hers Health Inc (NYSE: HIMS) has a price-to-earnings ratio that is above its average at 44.69x. The stock has a 36-month beta value of 1.08. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 2 as “overweight,” 8 as “hold,” and 0 as “sell.”
The public float for HIMS is 177.18M, and at present, short sellers hold a 19.10% of that float. On November 18, 2024, the average trading volume of HIMS was 12.17M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HIMS) stock’s latest price update
Hims & Hers Health Inc (NYSE: HIMS) has seen a decline in its stock price by -7.34 in relation to its previous close of 20.85. However, the company has experienced a -17.47% decline in its stock price over the last five trading sessions. fool.com reported 2024-11-16 that Hims & Hers has given back recent gains, but don’t overlook the company’s massive growth.
HIMS’s Market Performance
HIMS’s stock has fallen by -17.47% in the past week, with a monthly drop of -10.39% and a quarterly rise of 16.67%. The volatility ratio for the week is 15.67% while the volatility levels for the last 30 days are 9.92% for Hims & Hers Health Inc The simple moving average for the past 20 days is -13.94% for HIMS’s stock, with a 13.16% simple moving average for the past 200 days.
Analysts’ Opinion of HIMS
Needham, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $24. The rating they have provided for HIMS stocks is “Buy” according to the report published on August 22nd, 2024.
HIMS Trading at -2.21% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.53% of loss for the given period.
Volatility was left at 9.92%, however, over the last 30 days, the volatility rate increased by 15.67%, as shares sank -12.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +41.54% upper at present.
During the last 5 trading sessions, HIMS fell by -17.47%, which changed the moving average for the period of 200-days by +116.84% in comparison to the 20-day moving average, which settled at $22.45. In addition, Hims & Hers Health Inc saw 117.08% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Manuel Anja, who purchase 4,000 shares at the price of $26.94 back on Nov 12 ’24. After this action, Manuel Anja now owns 4,000 shares of Hims & Hers Health Inc, valued at $107,760 using the latest closing price.
Manuel Anja, the Director of Hims & Hers Health Inc, purchase 1,000 shares at $24.50 during a trade that took place back on Nov 14 ’24, which means that Manuel Anja is holding 5,000 shares at $24,500 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.78 for the gross margin
The net margin for Hims & Hers Health Inc stands at 0.08. The total capital return value is set at 0.08. Equity return is now at value 26.35, with 19.93 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at 105.2. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is 22.26.
Currently, EBITDA for the company is -19.94 million with net debt to EBITDA at -2.95. When we switch over and look at the enterprise to sales, we see a ratio of 3.14. The receivables turnover for the company is 271.53for trailing twelve months and the total asset turnover is 2.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.14.
Conclusion
To sum up, Hims & Hers Health Inc (HIMS) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
